Phase IB/II study of the HSP90 inhibitor AUY922, in combination with trastuzumab, in patients with HER2+ advanced breast cancer

dc.contributor.author	López López, Rafael
dc.date.accessioned	2017-06-07T07:05:28Z
dc.date.available	2017-06-07T07:05:28Z
dc.date.issued	2012
dc.identifier.issn	0732-183X
dc.identifier.uri	http://hdl.handle.net/20.500.11940/2468
dc.language.iso	eng
dc.title	Phase IB/II study of the HSP90 inhibitor AUY922, in combination with trastuzumab, in patients with HER2+ advanced breast cancer
dc.type	Publicación de congreso
dc.authorsophos	Kong, A
dc.authorsophos	Rea, D
dc.authorsophos	Ahmed, S
dc.authorsophos	Beck, J T
dc.authorsophos	Lopez, R L
dc.authorsophos	Biganzoli, L
dc.authorsophos	Armstrong, A
dc.authorsophos	Aglietta, M
dc.authorsophos	Alba, E
dc.authorsophos	Campone, M
dc.authorsophos	Akimov, M
dc.authorsophos	Matano, A
dc.authorsophos	Lefebvre, C
dc.authorsophos	Lee, S C
dc.identifier.isi	318009800005
dc.identifier.sophos	8819
dc.issue.number	15 SUPPL. 1
dc.journal.title	Journal Of Clinical Oncology
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Oncoloxía médica
dc.page.initial	530
dc.page.final	530
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	30

Files in this item

Files	Size	Format	View
There are no files associated with this item.